• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于AD8作为痴呆筛查工具的重新评估研究及文献综述。

A re-evaluation study and literature review on AD8 as a screening tool for dementia.

作者信息

Yang Cho-Hsiang, Lin Yi-Ting, Hsieh Ming H, Hwang Tzung-Jeng

机构信息

Department of Psychiatry, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan.

Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

PLoS One. 2025 May 5;20(5):e0321570. doi: 10.1371/journal.pone.0321570. eCollection 2025.

DOI:10.1371/journal.pone.0321570
PMID:40323929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12052112/
Abstract

BACKGROUND

The Eight-Item Informant Interview to Differentiate Aging and Dementia (AD8) was developed as a screening tool for dementia, with a cutoff score of 2 suggested by the initial study. However, various studies have reported different cutoff values, and many have found that a cutoff of 2 may result in a high false positive rate. Furthermore, a high false positive rate has repeatedly been shown when the AD8 is self-administered in local government screening programs in Taiwan.

OBJECTIVES

This study aimed to test the AD8's performance, define its best cutoff value, review factors that may affect its performance, and reconsider its role in clinical practice.

METHODS

We recruited 118 participant-informant dyads from a university teaching hospital. For each informant, the AD8 was administered before the Clinical Dementia Rating (CDR) to minimize recall bias. Two geriatric psychiatrists made a consensus clinical diagnosis for each participant based on the DSM-5 criteria. Receiver operating characteristic analysis was used to assess the performance of the AD8.

RESULTS

Thirty-seven participants had a CDR of 0, 61 had a CDR of 0.5, and 20 had a CDR ≥ 1. To discriminate between the participants with CDR 0 and those with CDR 0.5, the optimal cutoff score for the AD8 was 2. Including those with CDR ≥ 1 changed the best cutoff value to 3. In terms of the DSM-5 criteria, 59 participants had normal cognition, 28 had mild neurocognitive disorder, and 31 had major neurocognitive disorder or dementia. To discriminate between those with and without dementia, an AD8 cutoff value of 4 maximized the Youden index with more balanced sensitivity and specificity.

CONCLUSION

The AD8 may have different cutoff values depending on different purposes. Our findings suggest that the AD8 may perform better with a cutoff value of 4 to discriminate between those with and without dementia.

摘要

背景

用于区分衰老与痴呆的八项知情人访谈(AD8)被开发用作痴呆筛查工具,初始研究建议的临界值为2分。然而,多项研究报告了不同的临界值,且许多研究发现临界值为2分可能导致较高的假阳性率。此外,在台湾地方政府筛查项目中,AD8由本人自行填写时,反复出现较高的假阳性率。

目的

本研究旨在测试AD8的性能,确定其最佳临界值,评估可能影响其性能的因素,并重新审视其在临床实践中的作用。

方法

我们从一所大学教学医院招募了118对参与者-知情人。对于每位知情人,在临床痴呆评定量表(CDR)评定之前进行AD8评定,以尽量减少回忆偏倚。两名老年精神科医生根据《精神疾病诊断与统计手册》第五版(DSM-5)标准对每位参与者达成共识性临床诊断。采用受试者工作特征分析评估AD8的性能。

结果

37名参与者的CDR评分为0,61名参与者的CDR评分为0.5,20名参与者的CDR评分≥1。为区分CDR评分为0的参与者和CDR评分为0.5的参与者,AD8的最佳临界值为2分。纳入CDR评分≥1的参与者后,最佳临界值变为3分。根据DSM-5标准,59名参与者认知正常,28名参与者患有轻度神经认知障碍,31名参与者患有重度神经认知障碍或痴呆。为区分有痴呆和无痴呆的参与者,AD8临界值为4分时约登指数最大,敏感性和特异性更平衡。

结论

根据不同目的,AD8可能有不同的临界值。我们的研究结果表明,AD8临界值为4分时,在区分有痴呆和无痴呆参与者方面可能表现更佳。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28b/12052112/cfab4e1953bf/pone.0321570.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28b/12052112/242301f2d91a/pone.0321570.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28b/12052112/30f6a0ae7a4b/pone.0321570.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28b/12052112/cfab4e1953bf/pone.0321570.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28b/12052112/242301f2d91a/pone.0321570.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28b/12052112/30f6a0ae7a4b/pone.0321570.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28b/12052112/cfab4e1953bf/pone.0321570.g003.jpg

相似文献

1
A re-evaluation study and literature review on AD8 as a screening tool for dementia.一项关于AD8作为痴呆筛查工具的重新评估研究及文献综述。
PLoS One. 2025 May 5;20(5):e0321570. doi: 10.1371/journal.pone.0321570. eCollection 2025.
2
Detection of cognitive impairment using self-rated AD8 and informant-reported AD8.使用自我评估 AD8 和知情者报告 AD8 检测认知障碍。
J Formos Med Assoc. 2018 Jan;117(1):42-47. doi: 10.1016/j.jfma.2017.02.015. Epub 2017 Mar 21.
3
The Informant AD8 Can Discriminate Patients with Dementia From Healthy Control Participants in an Asian Older Cohort.知情者 AD8 可以在亚洲老年队列中区分痴呆患者和健康对照参与者。
J Am Med Dir Assoc. 2019 Jun;20(6):775-779. doi: 10.1016/j.jamda.2018.11.023. Epub 2019 Jan 17.
4
Validity and reliability of the Korean version of the AD8 informant interview (K-AD8) in dementia.中文版 AD8 知情者访谈(K-AD8)在痴呆症中的有效性和可靠性。
Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):371-6. doi: 10.1097/WAD.0b013e31819e6881.
5
The reliability and validity of the informant AD8 by comparison with a series of cognitive assessment tools in primary healthcare.在初级医疗保健中,通过与一系列认知评估工具相比较, informant AD8的可靠性和有效性。
Int Psychogeriatr. 2016 Mar;28(3):443-52. doi: 10.1017/S1041610215001702. Epub 2015 Oct 22.
6
Educational effects on ascertain dementia 8-item informant questionnaire to detect dementia in the Taiwanese population.教育对 8 项认知障碍知情者调查问卷检测台湾人群痴呆的影响。
Int Psychogeriatr. 2018 Aug;30(8):1189-1197. doi: 10.1017/S1041610217002733. Epub 2017 Dec 10.
7
The AD8: a brief informant interview to detect dementia.AD8:一种用于检测痴呆症的简短 informant 访谈。 (注:这里 informant 直译为“提供信息者”,在医学语境中可理解为访谈对象等,具体含义需结合上下文确定)
Neurology. 2005 Aug 23;65(4):559-64. doi: 10.1212/01.wnl.0000172958.95282.2a.
8
Informant-based dementia screening in a population-based sample of African Americans.在非裔美国人的基于人群的样本中进行基于信息提供者的痴呆筛查。
Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):117-23. doi: 10.1097/wad.0b013e318190a709.
9
Combining the AD8 and MMSE for community-based dementia screening.将 AD8 与 MMSE 相结合进行社区为基础的痴呆筛查。
Exp Gerontol. 2024 Sep;194:112482. doi: 10.1016/j.exger.2024.112482. Epub 2024 Jun 17.
10
The AD8 (Dementia Screening Interview) is a valid and reliable screening scale not only for dementia but also for mild cognitive impairment in the Turkish geriatric outpatients.AD8(痴呆筛查访谈)是一种有效且可靠的筛查量表,不仅可用于痴呆症,也可用于土耳其老年门诊患者的轻度认知障碍。
Int Psychogeriatr. 2019 Feb;31(2):223-229. doi: 10.1017/S1041610218000674. Epub 2018 Jun 20.

本文引用的文献

1
Evaluation of the Electronic Clinical Dementia Rating for Dementia Screening.电子临床痴呆评定量表用于痴呆筛查的评估。
JAMA Netw Open. 2023 Sep 5;6(9):e2333786. doi: 10.1001/jamanetworkopen.2023.33786.
2
Estimating Dementia Risk Using Multifactorial Prediction Models.使用多因素预测模型估算痴呆风险。
JAMA Netw Open. 2023 Jun 1;6(6):e2318132. doi: 10.1001/jamanetworkopen.2023.18132.
3
The Chinese version of informant AD8 for mild cognitive impairment and dementia screening in community-dwelling older adults.用于社区居住老年人轻度认知障碍和痴呆筛查的中文版知情者AD8量表
Public Health Nurs. 2023 Mar;40(2):258-265. doi: 10.1111/phn.13166. Epub 2023 Jan 12.
4
Development and validation of the Ascertain Dementia 8 (AD8) Thai version.《Ascertain Dementia 8(AD8)泰文版的编制与验证》。
Psychogeriatrics. 2022 Nov;22(6):795-801. doi: 10.1111/psyg.12884. Epub 2022 Aug 4.
5
Validity and reliability of the Farsi version of the ascertain dementia 8-item (AD8-F) informant interview in Iranian patients with mild neurocognitive disorder.伊朗轻度神经认知障碍患者使用阿兹海默病 8 项简易筛查量表(AD8-F)访谈进行评估的信度和效度研究。
BMC Geriatr. 2022 Oct 14;22(1):801. doi: 10.1186/s12877-022-03391-y.
6
Sum of boxes of the clinical dementia rating scale highly predicts conversion or reversion in predementia stages.临床痴呆评定量表的盒式总和高度预测轻度认知障碍阶段的转化或逆转。
Front Aging Neurosci. 2022 Sep 23;14:1021792. doi: 10.3389/fnagi.2022.1021792. eCollection 2022.
7
Contributions of Caregiver Management Styles to the Discrepancy Between Reported and Observed Task Performance in People with Dementia.照料者管理风格对痴呆患者报告和观察到的任务表现差异的影响。
J Alzheimers Dis. 2022;88(4):1605-1614. doi: 10.3233/JAD-220155.
8
Physical Examination in the Evaluation of Dementia.痴呆评估中的体格检查。
Med Clin North Am. 2022 May;106(3):471-482. doi: 10.1016/j.mcna.2021.12.009. Epub 2022 Apr 4.
9
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.2019 年全球痴呆症患病率估计及 2050 年预测患病率:2019 年全球疾病负担研究分析。
Lancet Public Health. 2022 Feb;7(2):e105-e125. doi: 10.1016/S2468-2667(21)00249-8. Epub 2022 Jan 6.
10
Validation of AD8-Philippines (AD8-P): A Brief Informant-Based Questionnaire for Dementia Screening in the Philippines.菲律宾版AD8问卷(AD8-P)的验证:一种基于 informant 的用于菲律宾痴呆筛查的简短问卷。
Int J Alzheimers Dis. 2021 Oct 31;2021:7750235. doi: 10.1155/2021/7750235. eCollection 2021.